President’s panel calls for more girls, boys to get HPV vaccine

Author: Government news release Source: consumer.healthday.com Too few American girls and boys are getting vaccinated against the cancer-causing human papillomavirus (HPV), the President's Cancer Panel reported Monday. HPV is linked to cervical cancer as well as penis, rectal and oral cancers. One in four adults in the United States is infected with at least one type of HPV. Increasing HPV vaccination rates could prevent a large number of cancer cases and save many lives, the panel said. "Today, there are two safe, effective, approved vaccines that prevent infection by the two most prevalent cancer-causing types, yet vaccination rates are far too low," Barbara Rimer, chair of the President's Cancer Panel, said in a panel news release. "We are confident that if HPV vaccination for girls and boys is made a public health priority, hundreds of thousands will be protected from these HPV-associated diseases and cancers over their lifetimes," she added. Currently, the U.S. Centers for Disease Control and Prevention is recommending that girls aged 11 and 12 receive either the Cervarix or Gardasil vaccines, and Gardasil is recommended for boys of similar age. In 2012, only a third of girls aged 13 to 17 got all three recommended doses of HPV vaccine, CDC data shows. That's much lower than the federal government's goal of having 80 percent of girls aged 13 to 15 fully vaccinated against HPV by 2020, the report said. The picture is even more disappointing for boys. Less than 7 percent of males aged 13 to 17 [...]

2014-02-11T13:11:27-07:00February, 2014|Oral Cancer News|

New Association found between Obesity in patients with Tongue Cancer

Source: US NewsPublished: February 7, 2014By: Robert Preidt, HealthDay Reporter  FRIDAY, Feb. 7, 2014 (HealthDay News) -- Obese people who are diagnosed with tongue cancer might be at increased risk of dying from the disease, a small new study finds. Researchers looked at about 150 people who had surgery for early stage squamous cell carcinoma of the tongue and found that obese patients had a five-fold increased risk of death. Three years after surgery, 87 percent of normal-weight patients were alive, compared with 68 percent of obese patients, according to the findings, which were published recently in the journal Cancer. The study is the first to link obesity and increased risk of death in patients with any type of head or neck cancer, the researchers said. They said previous studies have found an association between obesity and worse outcomes among patients with several common cancers, including breast and colon cancers. "The role of obesity across several common cancers is a focus of increased attention," study senior author Dr. Clifford Hudis, chief of breast cancer medicine at the Memorial Sloan Kettering Cancer Center in New York City, said in a center news release. Hudis is also president of the American Society of Clinical Oncology. Because the study was so specific in terms of the cancer's location in the body and disease stage, it helped clarify the effect of obesity, another researcher said. "Most prior research investigating the interaction between [obesity] and head and neck cancers included multiple tumor sites and disease [...]

2014-02-10T16:31:09-07:00February, 2014|Oral Cancer News|

Global burden of cancer is on the rise

Source: Medical News TodayPublished: Catherine Paddock, PHDBy: February 4, 2014  A new report from the World Health Organization's cancer agency reveals that cancer rates are growing at an "alarming pace" around the world and urges stronger efforts on prevention measures to curb the disease. The World Cancer Report 2014, from the World Health Organization's (WHO's) International Agency for Research on Cancer (IARC), estimates that the global burden of cancer will rise from an estimated 14 million new cases per year in 2012 to 22 million within the next 20 years. Due to growing and aging populations, developing countries are disproportionately affected by the growing numbers of cancers. Over 60% of the global burden is in Africa, Asia and Central and South America, where 70% of cancer deaths occur, and where lack of early detection and treatment is a growing problem. There is an urgent need to put in place measures to prevent the disease, says the report, adding that half of all cancers could be avoided if we use what we already know more effectively. Dr. Christopher Wild, report co-editor and director of the IARC, says: "Despite exciting advances, this Report shows that we cannot treat our way out of the cancer problem. More commitment to prevention and early detection is desperately needed in order to complement improved treatments and address the alarming rise in cancer burden globally." Leading cause of deaths worldwide, costs spiralling out of control Cancer is a leading cause of death worldwide - in 2012 the [...]

2014-02-06T14:44:36-07:00February, 2014|Oral Cancer News|

Confirming that HPV vaccine is not a causative factor for increased sexual behavior in teens

Source: Medical News TodayPublished: February 3, 2014  A new study may alleviate concerns that the human papillomavirus (HPV) vaccine leads to either the initiation of sex or unsafe sexual behaviors among teenage girls and young women. The Cincinnati Children's Hospital Medical Center study shows that teen girls' and young women's beliefs regarding the HPV vaccine, whether accurate or inaccurate, are not linked to subsequent sexual behaviors over the six months after vaccination. Those enrolled in the study didn't change their behavior whether they thought safer sex was less important or just as important after vaccination, or whether they thought the vaccine did or did not decrease the risk of sexually transmitted infections (STIs) other than HPV. The vast majority thought it was still important to practice safer sex after vaccination, and most did not believe that HPV vaccination protected against other STIs. The study is published in the eFirst pages of the journal Pediatrics. "We hope this study reassures parents, and thus improves HPV vaccination rates, which in turn will reduce rates of cervical and other cancers that can result from HPV infection," says Jessica Kahn, MD, a physician in the division of adolescent medicine at Cincinnati Children's. Dr. Kahn studied sexually experienced and inexperienced young teens and women between the ages of 13 and 21. More than 300 completed questionnaires immediately after receiving the vaccine, and most of them completed follow-up surveys again two and six months later. These surveys assessed demographics, knowledge and attitudes about the HPV vaccine, [...]

2014-02-06T14:24:20-07:00February, 2014|Oral Cancer News|

CVS Pharmacy ceases to promote one of the major causes of death in the U.S.: Tobacco.

Source: The Wall Street JournalPublished:  Feb. 5, 2014By: Timothy W. Martin And Mike Esterl  CVS said it would stop selling all cigarettes and tobacco products nationwide by October, saying they have no place in a drugstore company that is trying to become more of a health-care provider. Mike Esterl joins MoneyBeat. Photo: AP. CVS, the nation's second-largest pharmacy chain, said Wednesday that it would stop selling all cigarettes and tobacco products nationwide by October, saying they have no place in a drugstore company that is trying to become more of a health-care provider. The move is a bold and expensive one for CVS, a unit of Woonsocket, R.I.-based CVS Caremark Corp. CVS -1.01% It reflects a major push by retail pharmacies away from simply dispensing drugs toward a more integrated role of providing basic health services to Americans—including millions of newly insured—amid an expected shortage of primary care doctors. The news is another blow to the $100 billion tobacco industry that is wrestling with slumping sales, rising taxes, widening smoking bans and a resurgence of public information campaigns highlighting the perils of smoking. For CVS, the move will be costly. The drugstore chain estimates it will lose $2 billion in annual revenue from tobacco and other sundries as a result, which amounts to about six to nine cents a share this year and about 17 cents annually from next year on. CVS, with annual revenue of more than $123 billion, projects its 2014 earnings will be $4.36 to $4.50 a share. But [...]

2014-02-05T16:11:52-07:00February, 2014|Oral Cancer News|

FDA Efforts to Reduce Youth Smoking

Source: USA TodayPublished: February 4, 2014   WASHINGTON — The Food and Drug Administration is launching the government's largest effort yet to curb tobacco use among at-risk teens. The $115 million media campaign stems from the FDA's new authority to regulate tobacco, granted by a 2009 law, says commissioner Margaret Hamburg. The ads will target the roughly 10 million American teens who are open to smoking or are already experimenting with cigarettes, she says. That investment "is one of the most important efforts in recent times in the effort to reduce youth smoking," says Matthew Myers, president of the Campaign for Tobacco-Free Kids. "The FDA has carefully researched which ads will have the greatest impact on at-risk youth. These were designed with the same scientific rigor that Madison Avenue uses to market its products." Many "at-risk" kids see smoking as a temporary coping mechanism to help them deal with the "chaos" caused by poverty, violence or family turmoil, said Mitch Zeller, director of the FDA's Center for Tobacco Products. This ad dramatizes one of the real costs of smoking, namely that smoking can cause wrinkles that age you prematurely.(Photo: FDA) "We are not talking about happy-go-lucky kids," Zeller said. "They don't see themselves as smokers. They think they will be able to quit." Although the first round of ads will aim for a broad audience, later campaigns will target specific groups, such as gay teens and Native Americans, Zeller said. Ads from the campaign, called "The Real Cost," will run on [...]

2014-02-05T15:27:10-07:00February, 2014|Oral Cancer News|

As life expectancy goes up, cancer rates increase as well.

Source: CNNPublished: Tuesday, February 4, 2014By: Time Hume and Jen Christensen  http://youtu.be/zCHncLNJ2HI (CNN) -- Cancer cases are expected to surge 57% worldwide in the next 20 years, an imminent "human disaster" that will require a renewed focus on prevention to combat, according to the World Health Organization. The World Cancer Report, produced by the WHO's specialized cancer agency and released on World Cancer Day, predicts new cancer cases will rise from an estimated 14 million annually in 2012 to 22 million within two decades. Over the same period, cancer deaths are predicted to rise from 8.2 million a year to 13 million. The rising incidence of cancer, brought about chiefly by growing, aging populations worldwide, will require a heavier focus on preventive public health policies, said Christopher Wild, director of the International Agency for Research on Cancer. "We cannot treat our way out of the cancer problem," he said. "More commitment to prevention and early detection is desperately needed in order to complement improved treatments and address the alarming rise in cancer burden globally." The report notes that the rocketing cost of responding to the "cancer burden" -- in 2010, the economic cost of the disease worldwide was estimated at $1.16 trillion -- is hurting the economies of rich countries and beyond the means of poor ones. The report said about half of all cancers were preventable and could have been avoided if current medical knowledge was acted upon. The disease could be tackled by addressing lifestyle factors, such as [...]

2014-02-05T14:46:25-07:00February, 2014|Oral Cancer News|

An HPV Vaccination campaign to save boys’ lives

Source: The IndependentPublished: Sunday, February 2, 2014By: Charlie Cooper  Immunisation used against cervical cancer in girls can also prevent diseases in young men   The Government could save thousands of lives and hundreds of millions of pounds for the NHS by vaccinating boys against a cancer-causing virus at a cost of around £20m a year, a coalition of health experts and campaigners says. HPV Action, which has attracted the high-profile backing of leading charities and a medical royal college, wants the national vaccination programme against the human papilloma virus (HPV), currently only available to girls aged 12 to 13, to be extended to boys, amid growing evidence of the virus's role in causing cancers of the mouth and throat. Girls have been given the vaccine since 2008 to protect them against cervical cancer, which is known to be caused by HPV infection in most cases. But it is now well established that the sexually transmitted virus is also responsible for a significant proportion of cancers in other parts of the body, including the throat, anus and penis. Many scientists suspect it may be the root cause of rising rates of oral and throat cancers in both women and men. The campaign group will this week present new evidence from Denmark which counters the UK Government's assessment that vaccinating boys is unnecessary – and will argue that the human rights of British boys are being infringed by denying them the vaccine. Government experts last month began an investigation into the cost-effectiveness [...]

2014-02-03T17:49:23-07:00February, 2014|Oral Cancer News|
Go to Top